rs547488738
Positions:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2
The NM_001164278.2(SLC37A4):āc.1133G>Cā(p.Ser378Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000487 in 1,613,380 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.00026 ( 0 hom., cov: 33)
Exomes š: 0.00051 ( 9 hom. )
Consequence
SLC37A4
NM_001164278.2 missense
NM_001164278.2 missense
Scores
1
4
6
Clinical Significance
Conservation
PhyloP100: 5.62
Genes affected
SLC37A4 (HGNC:4061): (solute carrier family 37 member 4) This gene regulates glucose-6-phosphate transport from the cytoplasm to the lumen of the endoplasmic reticulum, in order to maintain glucose homeostasis. It also plays a role in ATP-mediated calcium sequestration in the lumen of the endoplasmic reticulum. Mutations in this gene have been associated with various forms of glycogen storage disease. Alternative splicing in this gene results in multiple transcript variants.[provided by RefSeq, Aug 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
PM1
In a transmembrane_region Helical (size 20) in uniprot entity G6PT1_HUMAN there are 4 pathogenic changes around while only 0 benign (100%) in NM_001164278.2
BP4
Computational evidence support a benign effect (MetaRNN=0.009851992).
BP6
Variant 11-119025247-C-G is Benign according to our data. Variant chr11-119025247-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 199062.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1, Benign=2}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000256 (39/152358) while in subpopulation SAS AF= 0.00807 (39/4832). AF 95% confidence interval is 0.00607. There are 0 homozygotes in gnomad4. There are 28 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC37A4 | NM_001164278.2 | c.1133G>C | p.Ser378Thr | missense_variant | 11/12 | NP_001157750.1 | ||
SLC37A4 | NM_001164277.2 | c.1067G>C | p.Ser356Thr | missense_variant | 10/11 | NP_001157749.1 | ||
SLC37A4 | NM_001164280.2 | c.1067G>C | p.Ser356Thr | missense_variant | 8/9 | NP_001157752.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC37A4 | ENST00000330775.9 | c.1067G>C | p.Ser356Thr | missense_variant | 9/10 | 5 | ENSP00000476242.2 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152240Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
39
AN:
152240
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00109 AC: 270AN: 247428Hom.: 3 AF XY: 0.00135 AC XY: 181AN XY: 134256
GnomAD3 exomes
AF:
AC:
270
AN:
247428
Hom.:
AF XY:
AC XY:
181
AN XY:
134256
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000511 AC: 747AN: 1461022Hom.: 9 Cov.: 34 AF XY: 0.000724 AC XY: 526AN XY: 726740
GnomAD4 exome
AF:
AC:
747
AN:
1461022
Hom.:
Cov.:
34
AF XY:
AC XY:
526
AN XY:
726740
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000256 AC: 39AN: 152358Hom.: 0 Cov.: 33 AF XY: 0.000376 AC XY: 28AN XY: 74514
GnomAD4 genome
AF:
AC:
39
AN:
152358
Hom.:
Cov.:
33
AF XY:
AC XY:
28
AN XY:
74514
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
144
Asia WGS
AF:
AC:
19
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 16, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Glucose-6-phosphate transport defect Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 12, 2019 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 09, 2022 | The p.S356T variant (also known as c.1067G>C), located in coding exon 7 of the SLC37A4 gene, results from a G to C substitution at nucleotide position 1067. The serine at codon 356 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
SLC37A4-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 16, 2022 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;T;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D;D
MetaRNN
Benign
T;T;T;T
PrimateAI
Uncertain
T
Sift4G
Uncertain
D;D;D;D
Vest4
MVP
MPC
0.026
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at